Provided by Tiger Trade Technology Pte. Ltd.

Larimar Therapeutics, Inc.

4.05
-0.1300-3.11%
Post-market: 3.93-0.1200-2.96%19:30 EDT
Volume:945.55K
Turnover:3.84M
Market Cap:421.20M
PE:-2.10
High:4.23
Open:4.23
Low:3.93
Close:4.18
52wk High:6.42
52wk Low:2.72
Shares:104.00M
Float Shares:57.54M
Volume Ratio:0.98
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9258
EPS(LYR):-2.2711
ROE:-139.63%
ROA:-70.96%
PB:3.31
PE(LYR):-1.78

Loading ...

Larimar Therapeutics Q4 EPS USD -0.73

THOMSON REUTERS
·
Mar 19

Larimar Therapeutics Q4 Operating Expenses USD 64.018 Million

THOMSON REUTERS
·
Mar 19

Larimar Therapeutics Inc - Topline Open Label Study Data Expected in Q2 2026

THOMSON REUTERS
·
Mar 19

James E. Flynn, Director, Acquires Larimar Therapeutics Common Shares

Reuters
·
Mar 03

Larimar Therapeutics Director Jeffrey W. Sherman Acquires Common Shares

Reuters
·
Mar 03

Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA) and Larimar Therapeutics (LRMR)

TIPRANKS
·
Feb 28

Top Premarket Decliners

MT Newswires Live
·
Feb 26

Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering

THOMSON REUTERS
·
Feb 26

Larimar Therapeutics Inc - Prices Upsized Public Offering at $5.00 per Share

THOMSON REUTERS
·
Feb 26

BUZZ-Larimar Therapeutics slips after $75 mln stock offering commenced

Reuters
·
Feb 26

Press Release: Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering

Dow Jones
·
Feb 26

Laminar Therapeutics Stock Is Popping Today: What's Going On?

Benzinga_recent_news
·
Feb 26

Larimar Therapeutics Up Over 64%, on Pace for Largest Percent Increase Since January 2016 -- Data Talk

Dow Jones
·
Feb 26

NASD Most Active Issues

Dow Jones
·
Feb 25

Larimar Therapeutics Up Nearly 32%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk

Dow Jones
·
Feb 25

BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSet

Reuters
·
Feb 24

BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, Constellation Energy, NRG Energy

Reuters
·
Feb 24

Larimar Therapeutics Shares up 35.6% Premarket on FDA's 'Breakthrough' Tag for Neurological Disorder Therapy

THOMSON REUTERS
·
Feb 24

BUZZ-Larimar jumps on FDA's 'breakthrough' tag for neurological disorder therapy

Reuters
·
Feb 24

Larimar Shares Jump Premarket on Breakthrough Therapy Designation for Lead Compound

Dow Jones
·
Feb 24